Yangchun Gu, Baoshan Cao. "Real-world study of first-line immunotherapy for EGFR/ALK wild-type advanced NSCLC: Analysis from the China National Cancer Center database.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e20584